Showing results (121-130 of 413) with videos related to
Sort By:
Pageof 42
Urologic Oncology|September 24, 2013
Validation of copy number variants associated with prostate cancer risk and prognosisAugust Blackburn, Desiree Wilson, Jonathan Gelfond, et al.American Journal of Epidemiology|August 10, 2010
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Marian L Neuhouser, et al.Plos One|October 3, 2012
Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrenceRoble G Bedolla, Jingjing Gong, Thomas J Prihoda, et al.The Journal of Urology|March 17, 2016
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate CancerDonna Pauler Ankerst, Jonathan Gelfond, Martin Goros, et al.Urology|May 10, 2011
Trends and co-trends of prostate-specific antigen and body mass index in a screened populationDonna P Ankerst, Brad H Pollock, Yuanyuan Liang, et al.Journal of Magnetic Resonance Imaging : JMRI|March 31, 2011
Fast T2*-weighted MRI of the prostate at 3 TeslaRulon L Hardman, Fadi El-Merhi, Adam J Jung, et al.Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.European Urology|September 1, 2015
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEdwin E Morales, Sonja Grill, Robert S Svatek, et al.Journal of Biomedical Informatics|May 20, 2015
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculatorsAndreas N Strobl, Andrew J Vickers, Ben Van Calster, et al.The Journal of Urology|January 13, 2006
Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black menJavier Hernández, Ivana Balic, Teresa L Johnson-Pais, et al.Pageof 42